Business
Change of Registered Office
Physiomics PLC announced a change of registered office, effective from October 1, 2025. The new registered office will be located at Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, OX14 4RY. Disclaimer*
About this update from Physiomics Plc
30 September 2025 Physiomics plc ("Physiomics" or the "Company") Change of Registered Office Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that, effective from 1 October 2025, its registered office will change to Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, OX14 4RY. For more information about Physiomics and its services, please visit www.physiomics.co.uk . Enquiries: Physiomics plc Dr Peter Sargent, CEO +44 (0)1235 841575 Hybridan LLP (Broker) Claire Louise Noyce +44 (0) 203 764 2341 Strand Hanson Ltd (NOMAD) James Dance & James Bellman +44 (0)20 7409 3494 Notes to Editor About Physiomics Physiomics plc combines expertise across Modelling & Simulation, Biostatistics, Data Science and Bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys. Our approach is to help derive insight from all relevant and often disparate data in order to de-risk decision making and optimise research design across discovery, pre-clinical and clinical studies. Through use of cutting-edge computational tools, bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, with over 140 targets and drugs modelled. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK.